HJB perfusion cell culture develops a robust, productive, high-quality upstream process for mAb, Fusion protein, engineered antibodies.
Using our reliable and science-based development platform, perfusion development can be with ease and speed of together with minimum or no scale up from pilot tox to GMP manufacturing, one can ensure consistent product quality and speed to clinic and commercial while reducing potential risks associated with tech transfer and scaling up.
• N-1 high density Fed-batch platform
• Concentrated Fed-batch platform
• Continuous perfusion platform
• Bench scale (ATF2) to GMP scale (ATF6 and ATF10)